Published in J Virol on April 01, 1988
Viral cysteine proteases are homologous to the trypsin-like family of serine proteases: structural and functional implications. Proc Natl Acad Sci U S A (1988) 4.32
Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes. Microbiol Rev (1993) 3.33
Poliovirus proteinase 3C: large-scale expression, purification, and specific cleavage activity on natural and synthetic substrates in vitro. J Virol (1988) 2.09
Nucleocytoplasmic traffic disorder induced by cardioviruses. J Virol (2006) 1.59
Bidirectional increase in permeability of nuclear envelope upon poliovirus infection and accompanying alterations of nuclear pores. J Virol (2004) 1.43
Determinants of substrate recognition by poliovirus 2A proteinase. J Virol (1992) 1.29
Relationship of eukaryotic initiation factor 3 to poliovirus-induced p220 cleavage activity. J Virol (1992) 1.25
Inhibition of proteolytic activity of poliovirus and rhinovirus 2A proteinases by elastase-specific inhibitors. J Virol (1993) 1.10
The multifaceted poliovirus 2A protease: regulation of gene expression by picornavirus proteases. J Biomed Biotechnol (2011) 1.05
Limited expression of poliovirus by vaccinia virus recombinants due to inhibition of the vector by proteinase 2A. J Virol (1990) 1.00
cis- and trans-cleavage activities of poliovirus 2A protease expressed in Escherichia coli. J Virol (1991) 0.90
Enzymatic characterization of refolded human rhinovirus type 14 2A protease expressed in Escherichia coli. J Virol (1998) 0.82
Challenge models to assess new therapies in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2012) 0.81
Ex vivo and in vivo inhibition of human rhinovirus replication by a new pseudosubstrate of viral 2A protease. J Virol (2011) 0.78
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Plaque formation and isolation of pure lines with poliomyelitis viruses. J Exp Med (1954) 68.67
Amino acid metabolism in mammalian cell cultures. Science (1959) 55.21
A rapid, sensitive, and specific method for the determination of protein in dilute solution. Anal Biochem (1973) 31.32
Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins. Science (1981) 23.67
Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature (1981) 16.61
Processing of adenovirus 2-induced proteins. J Virol (1973) 12.52
Polypeptide cleavages in the formation of poliovirus proteins. Proc Natl Acad Sci U S A (1968) 10.43
Evidence for large precursor proteins in poliovirus synthesis. Proc Natl Acad Sci U S A (1968) 8.24
Specific cleavage of viral proteins as steps in the synthesis and maturation of enteroviruses. Proc Natl Acad Sci U S A (1968) 5.64
The location of the polio genome protein in viral RNAs and its implication for RNA synthesis. Nature (1977) 5.61
A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein. Cell (1986) 5.53
Proteolytic processing of poliovirus polypeptides: antibodies to polypeptide P3-7c inhibit cleavage at glutamine-glycine pairs. Proc Natl Acad Sci U S A (1982) 5.50
Polyadenylic acid at the 3'-terminus of poliovirus RNA. Proc Natl Acad Sci U S A (1972) 5.42
Systematic nomenclature of picornavirus proteins. J Virol (1984) 5.26
STUDIES ON THE MECHANISM OF POLIOVIRUS-INDUCED CELL DAMAGE. I. THE RELATION BETWEEN POLIOVIRUS,-INDUCED METABOLIC AND MORPHOLOGICAL ALTERATIONS IN CULTURED CELLS. Virology (1965) 5.21
Poliovirus mutant that does not selectively inhibit host cell protein synthesis. Mol Cell Biol (1985) 4.94
Expression of animal virus genomes. Bacteriol Rev (1971) 4.33
Translation of encephalomyocarditis virus RNA in vitro yields an active proteolytic processing enzyme. Eur J Biochem (1978) 4.16
Protease required for processing picornaviral coat protein resides in the viral replicase gene. J Virol (1979) 3.70
Translation of encephalomyocarditis virus RNA in reticulocyte lysates: kinetic analysis of the formation of virion proteins and a protein required for processing. J Virol (1979) 3.64
Characterization of the large picornaviral polypeptides produced in the presence of zinc ion. J Virol (1974) 3.36
Evidence for intramolecular self-cleavage of picornaviral replicase precursors. J Virol (1982) 3.03
Similarity in gene organization and homology between proteins of animal picornaviruses and a plant comovirus suggest common ancestry of these virus families. Nucleic Acids Res (1984) 2.99
Implications of the picornavirus capsid structure for polyprotein processing. Proc Natl Acad Sci U S A (1987) 2.99
Expression of a cloned gene segment of poliovirus in E. coli: evidence for autocatalytic production of the viral proteinase. Cell (1984) 2.29
Cleavage of the cap binding protein complex polypeptide p220 is not effected by the second poliovirus protease 2A. Virology (1986) 2.02
Rhinoviruses. Annu Rev Microbiol (1972) 1.90
Demonstration in vitro that eucaryotic initiation factor 3 is active but that a cap-binding protein complex is inactive in poliovirus-infected HeLa cells. J Virol (1984) 1.87
Poliovirus-induced inhibition of host-cell protein synthesis. Cell (1982) 1.79
The activation reaction of papain. Biochim Biophys Acta (1967) 1.66
Association of poliovirus proteins with the endoplasmic reticulum. J Virol (1984) 1.57
In vitro synthesis and assembly of picornaviral capsid intermediate structures. J Virol (1982) 1.56
Isolation and structural characterization of cap-binding proteins from poliovirus-infected HeLa cells. J Virol (1985) 1.51
Translation of foot-and-mouth disease virion RNA and processing of the primary cleavage products in a rabbit reticulocyte lysate. Virology (1982) 1.44
Encephalomyocarditis virus-specific polypeptide p22 is involved in the processing of the viral precursor polypeptides. FEBS Lett (1979) 1.39
Poliovirus-encoded proteinase 3C: a possible evolutionary link between cellular serine and cysteine proteinase families. FEBS Lett (1986) 1.34
A comparative chemical and serological study of the full and empty particles of foot-and mouth disease virus. J Gen Virol (1975) 1.27
Molecular cloning and sequence determination of the genomic regions encoding protease and genome-linked protein of three picornaviruses. J Virol (1986) 1.23
Encephalomyocarditis virus-specific polypeptide p22 possessing a proteolytic activity: preliminary mapping on the viral genome. FEBS Lett (1979) 1.14
The ribosomal serine proteinase, cathepsin R. Occurrence in rat-liver ribosomes in a cryptic form. Eur J Biochem (1982) 0.81
Structure and replication of echovirus type 12. 1. Analysis of the polypeptides and RNA of echovirus 12 particles. Eur J Biochem (1978) 0.80
[Internal homology in the primary structure of the polyprotein of the poliovirus: the possible existence of 2 viral proteinases]. Dokl Akad Nauk SSSR (1985) 0.80
Processing of mengovirus precursor polypeptides in the presence of zinc ions and sulfhydryl compounds. J Virol (1976) 0.80
Structure and replication of echovirus type 12. 2. Viral polypeptides synthesized in the infected cell. Eur J Biochem (1978) 0.79
Functional association of cyclophilin A with HIV-1 virions. Nature (1994) 6.82
Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Antimicrob Agents Chemother (1994) 2.26
A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques. J Virol (1998) 1.79
Incomplete particles of adenovirus. II. Kinetics of formation and polypeptide composition of adenovirus type 2. Virology (1974) 1.74
Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry. Antimicrob Agents Chemother (1996) 1.51
Insertion mutations in the control region of the Gal operon of E. coli. I. Biological characterization of the mutations. Mol Gen Genet (1972) 1.44
Tryptic fingerprint analysis of adenovirus types 2, 5 and 12 DNA-Binding proteins. Virology (1976) 1.35
Adenovirus-infected, cell-specific, DNA-binding proteins. Cold Spring Harb Symp Quant Biol (1975) 1.34
Early processes of echovirus 12-infection: elution, penetration, and uncoating under the influence of rhodanine. Virology (1979) 1.24
Molecular cloning and sequence determination of the genomic regions encoding protease and genome-linked protein of three picornaviruses. J Virol (1986) 1.23
The relationship between group C adenovirus tumor antigen and the adenovirus single-strand DNA-binding protein. Cell (1976) 1.19
Isolation and characterization of adenovirus type 12 DNA binding proteins. Virology (1975) 1.18
2'-Fluorinated arabinonucleosides of 5-(2-haloalkyl)uracil: synthesis and antiviral activity. J Med Chem (1987) 0.99
Comparison of in vitro and in vivo infectivity of different clade B HIV-1 envelope chimeric simian/human immunodeficiency viruses in Macaca mulatta. Virology (1997) 0.96
In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophages. J Leukoc Biol (1994) 0.96
IgG isotype distribution of local and systemic immune responses induced by influenza virus infection. Eur J Immunol (1994) 0.95
Immunostimulatory, but not antiendotoxin, activity of lipid X is due to small amounts of contaminating N,O-acylated disaccharide-1-phosphate: in vitro and in vivo reevaluation of the biological activity of synthetic lipid X. Infect Immun (1991) 0.95
Plasmodium vivax: in vitro antiparasitic effect of cyclosporins. Exp Parasitol (1996) 0.94
The interleukin-17 gene of herpesvirus saimiri. J Virol (1998) 0.92
Novel thiosemicarbazones derived from formyl- and acyldiazines: synthesis, effects on cell proliferation, and synergism with antiviral agents. J Med Chem (1992) 0.91
HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates. Immunol Lett (1999) 0.90
Biochemistry and pathogenicity of echovirus 9. I. Characterization of the virus particles of strains Barty and Hill. Virology (1982) 0.90
Herpesvirus saimiri vFLIP provides an antiapoptotic function but is not essential for viral replication, transformation, or pathogenicity. J Virol (2000) 0.88
Characterization of an adenovirus early protein required for viral DNA replication: a single strand specific DNA binding proteins. Mol Cell Biochem (1976) 0.86
5-(Haloalkyl)-2'-deoxyuridines: a novel type of potent antiviral nucleoside analogue. J Med Chem (1985) 0.85
T-cell lymphoma caused by herpesvirus saimiri C488 independently of ie14/vsag, a viral gene with superantigen homology. J Virol (1998) 0.84
Independence of herpesvirus-induced T cell lymphoma from viral cyclin D homologue. J Exp Med (2001) 0.84
Measurement of HIV-1 reverse transcriptase by a nonradioactive assay system. Ann N Y Acad Sci (1992) 0.83
Synthesis and antiviral activity of thiosemicarbazone derivatives of pyridazinecarbaldehydes and alkyl pyridazinyl ketones. Arzneimittelforschung (1989) 0.82
Selective in vitro and in vivo activities of 5-(2-haloalkyl)pyrimidine nucleoside analogs, particularly 5-(2-chloroethyl)-2'-deoxyuridine, against herpes simplex virus. Antimicrob Agents Chemother (1985) 0.81
Inhibitors of HIV-1 proteinase containing 2-heterosubstituted 4-amino-3-hydroxy-5-phenylpentanoic acid: synthesis, enzyme inhibition, and antiviral activity. J Med Chem (1994) 0.81
Structure and replication of echovirus type 12. 1. Analysis of the polypeptides and RNA of echovirus 12 particles. Eur J Biochem (1978) 0.80
Interactions of HIV-1 proteins with human T-cell cyclophilin A. Ann N Y Acad Sci (1996) 0.80
Structure and replication of echovirus type 12. 2. Viral polypeptides synthesized in the infected cell. Eur J Biochem (1978) 0.79
Mechanism of action of 5-(2-chloroethyl)-2'-deoxyuridine, a selective inhibitor of herpes simplex virus replication. Mol Pharmacol (1990) 0.79
SDZ PRI 053, an orally bioavailable human immunodeficiency virus type 1 proteinase inhibitor containing the 2-aminobenzylstatine moiety. Antimicrob Agents Chemother (1995) 0.79
The use of cyclosporine, FK506, and SDZ NIM811 to prevent CD25- quiescent peripheral blood mononuclear cells from producing human immunodeficiency virus. J Infect Dis (1996) 0.79
Phosphonoformate and phosphonoacetate derivatives of 5-substituted 2'-deoxyuridines: synthesis and antiviral activity. J Med Chem (1988) 0.79
IgG isotype-specific auto-antibodies bind preferentially to cross-linked membrane Ig. Int Immunol (1995) 0.79
Biologically active protease 3C of human rhinovirus 1A is expressed from a cloned cDNA segment in Escherichia coli. Virology (1991) 0.78
A new class of mutants with an elevated basal level of the galactose enzymes in E. coli. Mol Gen Genet (1972) 0.78
Isolation and characterization of temperature-sensitive mutants of echovirus 12. Virology (1979) 0.78
HIV proteinase inhibitors containing 2-aminobenzylstatine as a novel scissile bond replacement: biochemical and pharmacological characterization. Antiviral Res (1994) 0.77
A vaccine strategy utilizing a combination of three different chimeric vectors which share specific vaccine antigens. J Med Primatol (2000) 0.77
Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14. J Mol Biol (1996) 0.77
Kinetics and isotype profile of rheumatoid factor production during viral infection: organ distribution of antibody secreting cells. Scand J Immunol (1996) 0.77
Inhibitors of human immunodeficiency virus type 1 protease containing 2-aminobenzyl-substituted 4-amino-3-hydroxy-5-phenylpentanoic acid: synthesis, activity, and oral bioavailability. J Med Chem (1996) 0.77
Isolation and characterization of an arildone-resistant poliovirus 2 mutant with an altered capsid protein VP1. Antiviral Res (1988) 0.77
Characteristics of a pathogenic molecular clone of an end-stage serum-derived variant of simian immunodeficiency virus (SIV(F359)). J Virol (2001) 0.76
[Thiophene as a structural element of physiologically active substances. 12. Thiophene analogs of antiviral chalcones]. Arch Pharm (Weinheim) (1985) 0.75
5-(2-Chloroethyl)-2'-deoxyuridine: a potent and selective inhibitor of herpes viruses in vitro and in vivo. Antiviral Res (1985) 0.75
Efforts to broaden HIV-1-specific immunity by boosting with heterologous peptides or envelope protein and the influence of prior exposure to virus. J Med Primatol (1999) 0.75
[Thiophene as a structural element of physiologically active substances. 11. Substituted thieno[2,3-d]imidazoles as potential antiviral agents]. Arch Pharm (Weinheim) (1985) 0.75
Paracyclophanes: a novel class of water-soluble inhibitors of HIV proteinase. J Med Chem (1996) 0.75
Biochemistry and pathogenicity of echovirus 9. II. Mutants of echovirus 9, strain Hill, with altered capsid surface properties. Virology (1986) 0.75
Echovirus 12-induced host cell shutoff is prevented by rhodanine. Nature (1977) 0.75
[Thiophene as a structural element of physiologically active substances. 13. Thiophene analogs of antiviral flavanes]. Arch Pharm (Weinheim) (1985) 0.75